Research & Development
US FDA Clears Neonatal Indication for O3Regional Oximetry
11 June 2019 - - US-based medical technology company Masimo's (NASDAQ: MASI) O3 Regional Oximetry has received FDA clearance for use on neonatal and infant patients (
Login
Username:

Password:


Related Headlines